Home › Major Depressive Disorder › Georgia › Johns Creek
Major Depressive Disorder clinical trials in Johns Creek, GA
7 studies for Major Depressive Disorder are looking for participants at sites in and around Johns Creek (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RecruitingPhase 3
- Accelerated Clinical Research Group LLC, Snellville · 16 mi away
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 2
- Evergreen Clinical Trials, Norcross · 6 mi away
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RecruitingPhase 3
- Vanda Investigational Site, Snellville · 16 mi away
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
RecruitingPhase 3
- Clinical Research Site, Norcross · 6 mi away
- Clinical Research Site, Snellville · 16 mi away
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
RecruitingPhase 2
- Evergreen Clinical Trials - Norcross /ID# 279421, Norcross · 6 mi away
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
RecruitingPhase 2
- Autobahn Site #142, Peachtree Corners · 4 mi away
Study of ALTO-300 in MDD
RecruitingPhase 2
- Site 208, Snellville · 16 mi away
Major Depressive Disorder trials in other cities
- New York City, NY37 studies
- Boston, MA31 studies
- Atlanta, GA25 studies
- Philadelphia, PA23 studies
- Orlando, FL19 studies
- Miami, FL18 studies
- Chicago, IL17 studies
- Tampa, FL17 studies
- Houston, TX16 studies
- San Diego, CA16 studies
- Little Rock, AR14 studies
- Orange, CA13 studies
Other studies in Johns Creek
- Obesity16 studies
- Overweight14 studies
- Schizophrenia8 studies
- Type 2 Diabetes8 studies
- Lung Cancer6 studies
- Heart Failure5 studies
- Non-Small Cell Lung Cancer5 studies
- High Blood Pressure4 studies
- Breast Cancer4 studies
- Atrial Fibrillation4 studies
- Chronic Kidney Disease3 studies
- IGA Glomerulonephritis3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.